Received Jan 22, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 2 | 943193 | IM / RA |
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | 1 | 006889 | IM / RA |
He developed numbness/tingling of hands and feet that progressed up legs. Dx Guillan Barre requiring inpatient treatment - ICU and intubation due to progressive quadriparesis, facial weakness, and respiratory failure.
None
Hypertension, Hyperlipidemia
Lisinopril Multivitamin Rosuvastatin
None
See continuation page